Skip to main content

Nantahala Capital Management, LLC

Position in SLN — Silence Therapeutics plc

CIK 1472322 New Canaan, CT

Position in SLN

as of Jun 30, 2026 · filed Aug 19, 2026
Position Value
$14,787,106
+$3,473,834 QoQ
Shares Held
1,346,731
-37.3% QoQ
Ownership
2.17%
of shares outstanding
% of Portfolio
0.90%
of 13F equity value
Holder Rank
#4
of 72 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SLN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Nantahala Capital Management, LLC holds $620,287,047 across 52 Biotechnology names. SLN ranks #20 (2.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SLN

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $14,787,106 1,346,731
2026-03-31 $11,313,272 2,146,731
2025-12-31 $9,377,956 1,542,427
2025-09-30 $5,410,196 1,042,427
2025-06-30 $6,046,076 1,042,427
2025-03-31 $2,939,644 1,042,427
2024-12-31 $7,221,770 1,049,676
2024-09-30 $3,636,000 200,000
2024-06-30 $3,800,000 200,000
2024-03-31 $4,320,000 200,000